PFE Latest Headlines

Goldman’s top 50 Weak Balance Sheet stocks

at seekingalpha.com (Sun, 5-May 5:14 PM)

About 79% of the S&P 500 names beat on EPS during the busiest week of Q1 reporting - Earnings Scorecard

at seekingalpha.com (Sun, 5-May 4:08 PM)

16 out of 24 health care companies beat topline numbers this week- Earnings scorecard

at seekingalpha.com (Sat, 4-May 4:47 PM)

Pharma R&D productivity seen improving for the first time in years - Deloitte

at seekingalpha.com (Sat, 4-May 3:30 PM)

Amgen stock rallies 13% on GLP-1 weight-loss drug update

at seekingalpha.com (Fri, 3-May 10:28 AM)

Analysts Conflicted on These Healthcare Names: InMode (INMD) and Pfizer (PFE)

at www.tipranks.com (Thu, 2-May 4:10 PM)

Moderna to seek parity for RSV shot as rivals lead in market

at seekingalpha.com (Thu, 2-May 1:48 PM)

Pfizer Exceeds Q1 Expectations with Strong Earnings and Raises 2024 Guidance: A Buy Rating by Evan Seigerman

at www.tipranks.com (Thu, 2-May 7:38 AM)

Analysts Have Conflicting Sentiments on These Healthcare Companies: Pfizer (PFE), Sagimet Biosciences, Inc. Class A (SGMT) and Alkermes (ALKS)

at www.tipranks.com (Thu, 2-May 6:32 AM)

Pfizer’s Mixed Financial Signals: A Delicate Balance Between Growth and Uncertainty

at www.tipranks.com (Thu, 2-May 5:20 AM)

Pfizer (PFE) Receives a Hold from Barclays

at www.tipranks.com (Thu, 2-May 3:50 AM)

Investor Optimism Improves Slightly Following Fed Decision

at www.benzinga.com (Thu, 2-May 2:37 AM)

PFE Call Spread is Attractively Offered at $0.14; Theoretical Value $0.11

Market Chameleon (Wed, 1-May 10:53 AM)